Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Protein Kinases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02439138
What this trial is testing

Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor Idelalisib (GS-1101) in Waldenström Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 5
Early research (Phase 1)Study completedNCT00001444
What this trial is testing

A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms

Who this might be right for
Breast CancerLymphomaNeoplasm+1 more
National Cancer Institute (NCI) 51
Not applicableUnknownNCT02635269
What this trial is testing

Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy

Who this might be right for
Metabolism, Inborn ErrorsLipid Metabolism, Inborn ErrorsCarbohydrate Metabolism, Inborn Errors+20 more
Rigshospitalet, Denmark 60
Large-scale testing (Phase 3)Looking for participantsNCT07804186
What this trial is testing

Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma

Who this might be right for
Uveal Melanoma
IDEAYA Biosciences 450
Testing effectiveness (Phase 2)Study completedNCT01109069
What this trial is testing

Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaDiffuse Well-differentiated Lymphocytic Lymphoma+7 more
Pharmacyclics LLC. 199
Testing effectiveness (Phase 2)Study completedNCT00481052
What this trial is testing

Nilotinib as First-line Treatment of Ph+ CML in Early Chronic Phase

Who this might be right for
Chronic Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 74
Early research (Phase 1)Study completedNCT05002140
What this trial is testing

Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer Patients

Who this might be right for
MetastasisLocally Advanced Solid TumorRecurrent Cancer
XRad Therapeutics Inc 12
Testing effectiveness (Phase 2)Study completedNCT00391989
What this trial is testing

Treatment of Adult Ph+ LAL With BMS-354825

Who this might be right for
Lymphoblastic Leukemia, Acute
Gruppo Italiano Malattie EMatologiche dell'Adulto 53
Testing effectiveness (Phase 2)Study completedNCT00785954
What this trial is testing

Safety and Efficacy Study of KAI-9803 to Treat Subjects With ST Elevation Myocardial Infarction [Heart Attack]

Who this might be right for
Myocardial InfarctionCardiovascular DiseasesPathologic Processes
KAI Pharmaceuticals 1,180
Testing effectiveness (Phase 2)WithdrawnNCT03109301
What this trial is testing

Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
Neoplasms, Nerve TissueNeurofibromatosis 1Heredodegenerative Disorders, Nervous System+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT02757326
What this trial is testing

ABC294640 (Opaganib) in Refractory / Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma
RedHill Biopharma Limited 13
Early research (Phase 1)Study completedNCT02144038
What this trial is testing

Study of the Safety and Effectiveness of LGH447 and BYL719 in Patients With Relapsed and Refractory Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma
Novartis Pharmaceuticals 20
Large-scale testing (Phase 3)Active Not RecruitingNCT06970743
What this trial is testing

BGB-16673 Compared to Investigator's Choice in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Covalent Bruton Tyrosine Kinase (BTK) Inhibitors

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
BeOne Medicines 153
Early research (Phase 1)Ended earlyNCT03116971
What this trial is testing

Phase Ib/II Study of M3814 With Etoposide and Cisplatin in Small Cell Lung Cancer (SCLC) Extensive Disease (ED)

Who this might be right for
Small Cell Lung Cancer
EMD Serono Research & Development Institute, Inc. 2
Testing effectiveness (Phase 2)Study completedNCT03233230
What this trial is testing

Phase IIb Study of Evobrutinib in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
EMD Serono Research & Development Institute, Inc. 390
Early research (Phase 1)Ended earlyNCT02601378
What this trial is testing

A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma.

Who this might be right for
Uveal Melanoma
Novartis Pharmaceuticals 107
Testing effectiveness (Phase 2)Active Not RecruitingNCT03162536
What this trial is testing

Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

Who this might be right for
Lymphoma, B-CellSmall Lymphocytic LymphomaChronic Lymphocytic Leukemia+6 more
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 190
Early research (Phase 1)Study completedNCT01594398
What this trial is testing

Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerNon Small Cell Lung Cancer (NSCLC)Breast Cancer+1 more
Syndax Pharmaceuticals 14
Testing effectiveness (Phase 2)Study completedNCT01720173
What this trial is testing

Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
Gynecologic Oncology Group 30
Early research (Phase 1)Study completedNCT00697346
What this trial is testing

Study of MLN8237 in Participants With Advanced Hematological Malignancies

Who this might be right for
B-cell Follicular LymphomaB-cell Marginal Zone LymphomaDiffuse Large B-cell Lymphoma+10 more
Millennium Pharmaceuticals, Inc. 58
Next Page